Stock Scorecard
Stock Summary for Surgery Partners Inc (SGRY) - $23.95 as of 3/28/2025 8:58:44 PM EST
Total Score
5 out of 30
Safety Score
41 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SGRY
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SGRY
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SGRY
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SGRY
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for SGRY (41 out of 100)
Stock Price Rating (Max of 10) | 7 |
Historical Stock Price Rating (Max of 10) | 9 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 5 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 3 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 5 |
Trading Volume (Max of 10) | 6 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SGRY
Financial Details for SGRY
Company Overview |
|
---|---|
Ticker | SGRY |
Company Name | Surgery Partners Inc |
Country | USA |
Description | Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company is headquartered in Brentwood, Tennessee. |
Sector Name | LIFE SCIENCES |
Industry Name | SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC |
Most Recent Quarter | 12/31/2024 |
Next Earnings Date | 5/5/2025 |
Stock Price History |
|
Last Day Price | 23.95 |
Price 4 Years Ago | 53.41 |
Last Day Price Updated | 3/28/2025 8:58:44 PM EST |
Last Day Volume | 604,842 |
Average Daily Volume | 1,067,258 |
52-Week High | 33.97 |
52-Week Low | 19.50 |
Last Price to 52 Week Low | 22.82% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 10.11 |
Sector PE | 40.10 |
5-Year Average PE | -45.61 |
Free Cash Flow Ratio | 13.76 |
Industry Free Cash Flow Ratio | 44.53 |
Sector Free Cash Flow Ratio | 47.05 |
Current Ratio Most Recent Quarter | 1.80 |
Total Cash Per Share | 1.74 |
Book Value Per Share Most Recent Quarter | 14.18 |
Price to Book Ratio | 1.72 |
Industry Price to Book Ratio | 99.43 |
Sector Price to Book Ratio | 21.92 |
Price to Sales Ratio Twelve Trailing Months | 0.99 |
Industry Price to Sales Ratio Twelve Trailing Months | 0.85 |
Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
Analyst Buy Ratings | 8 |
Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
Total Shares Outstanding | 127,613,000 |
Market Capitalization | 3,056,331,350 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 78.21% |
Reported EPS 12 Trailing Months | -1.33 |
Reported EPS Past Year | 0.50 |
Reported EPS Prior Year | 0.99 |
Net Income Twelve Trailing Months | -60,600,000 |
Net Income Past Year | -11,900,000 |
Net Income Prior Year | -54,600,000 |
Quarterly Revenue Growth YOY | 17.50% |
5-Year Revenue Growth | 8.63% |
Operating Margin Twelve Trailing Months | 20.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 221,800,000 |
Total Cash Past Year | 195,900,000 |
Total Cash Prior Year | 282,900,000 |
Net Cash Position Most Recent Quarter | -2,872,400,000 |
Net Cash Position Past Year | -2,607,900,000 |
Long Term Debt Past Year | 2,803,800,000 |
Long Term Debt Prior Year | 2,634,100,000 |
Total Debt Most Recent Quarter | 3,094,200,000 |
Equity to Debt Ratio Past Year | 0.41 |
Equity to Debt Ratio Most Recent Quarter | 0.38 |
Total Stockholder Equity Past Year | 1,987,200,000 |
Total Stockholder Equity Prior Year | 1,998,200,000 |
Total Stockholder Equity Most Recent Quarter | 1,896,500,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 163,400,000 |
Free Cash Flow Per Share Twelve Trailing Months | 1.28 |
Free Cash Flow Past Year | 205,000,000 |
Free Cash Flow Prior Year | 78,200,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.11 |
MACD Signal | -0.07 |
20-Day Bollinger Lower Band | 18.26 |
20-Day Bollinger Middle Band | 23.27 |
20-Day Bollinger Upper Band | 28.28 |
Beta | 2.74 |
RSI | 49.84 |
50-Day SMA | 26.33 |
150-Day SMA | 30.54 |
200-Day SMA | 35.59 |
System |
|
Modified | 3/28/2025 7:06:20 AM EST |